Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants

@article{Katz2002EnhancingTT,
  title={Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants},
  author={Martin M. Katz and Uriel M Halbreich and Charles L. Bowden and Alan Frazer and Roger M. Pinder and A. John Rush and David P Wheatley and Barry D. Lebowitz},
  journal={Neuropsychopharmacology},
  year={2002},
  volume={27},
  pages={319-328}
}
Concern about disappointing results from recent multi-center trials of new antidepressants prompted several ACNP workshops on “improving the technology of clinical trials.” The workshops focused on technical problems, such as patient screening, reliability of clinical ratings, and the role of the placebo control. They aimed to determine how to more… CONTINUE READING